The technology keeps moving.
AI capabilities are evolving continuously. What seems experimental today can become relevant within months, while new approaches quickly overtake established ones.
Build a clear plan for implementation, adoption, and measuring value with the HTO Applied AI Framework and a continuously updated library of practical use cases. Expert guidance and peers working on similar projects help you apply the method to your own work.
AI capabilities are evolving continuously. What seems experimental today can become relevant within months, while new approaches quickly overtake established ones.
Every advance changes what is possible across the pharma and life sciences sectors. Keeping up with the most relevant use cases, how organizations apply them, and where they create value requires ongoing attention.
Each use case raises questions about GxP, validation, governance, data, IT risk, and auditability. Regulatory expectations are evolving alongside the technology, making it harder to determine what responsible implementation requires.
We continuously update examples that show how organizations apply AI across pharma and life sciences, where it creates value, and what implementation involves.
We curate relevant developments and explain their implications for life sciences organizations, projects, and future opportunities.
Follow changes across GxP, validation, governance, data, and emerging regulatory expectations that can affect AI initiatives.
Join live sessions with specialists who can explain developments, examine real cases, and answer questions about technology, implementation, adoption, and regulation.
Learn from professionals responsible for similar AI use cases and projects. Compare approaches, share experiences, and understand how other organizations are responding.
Use the HTO Applied AI Framework, guided learning, templates, and decision tools to identify the right use cases, build strong business cases, and develop clear implementation and adoption strategies.
Explore our growing collection of AI use cases across drug discovery, clinical development, manufacturing, quality, regulatory, supply chain, and commercial operations.
Follow practical examples of how pharmaceutical and life sciences organizations are using emerging AI capabilities.
Each use case explains the problem it addresses, the potential value, the technology involved, and the maturity of the approach.
Understand the data, integration, GxP, validation, governance, ownership, and organizational considerations involved.
We update each use case as the technology, evidence, regulatory expectations, and implementation experience evolve.
The volume and speed of AI news make it difficult to identify the developments that deserve attention. We focus on the changes with practical implications for pharma and life sciences.
Follow new capabilities, models, platforms, research, and tools that could enable or reshape high-impact use cases.
Each update explains what has changed, which use cases it could affect, and what questions organizations should begin asking.
Understand how new developments could influence use-case portfolios, business cases, technology decisions, implementation plans, and existing risks.
AI initiatives in pharma and life sciences must work within GxP, validation, governance, data, and audit requirements.
Follow emerging guidance, policy changes, and regulatory discussions that can affect how organizations evaluate and implement AI.
Understand the questions a use case may raise around intended use, risk, evidence, validation, oversight, and auditability.
Consider governance, accountability, data, monitoring, and human oversight while teams shape the use case.
Access to relevant people helps turn information into better judgment. Members can compare approaches, ask practical questions, and learn from experience across the industry.
Join regular sessions with specialists who examine developments, walk through cases, and answer questions about technology, implementation, adoption, and regulation.
Learn from professionals responsible for similar AI use cases and projects. See how other organizations evaluate opportunities, handle challenges, and move initiatives forward.
Built around empathetic, curious, value-led, and practical principles, where members can discuss uncertainty, share lessons, and challenge ideas constructively.
The HTO Applied AI Framework provides a structured way to move from an emerging opportunity to a credible use case, business case, and implementation strategy.
Guided learning, templates, and decision tools help members apply each part of the framework to real AI initiatives.
Connect AI opportunities to strategic priorities, operational challenges, available capabilities, and the value the organization needs to create.
Clarify the problem, expected value, feasibility, risk, ownership, investment requirements, and criteria for success.
Plan the technology, data, governance, validation, operating model, and stakeholder involvement required to move the use case forward.
Identify who needs to use the solution, what needs to change, how the team will support adoption, and how the organization will measure value over time.
We built this membership for you if you identify, evaluate, prioritize, or deliver AI use cases and projects in pharma and life sciences.
You may be a project manager, change lead, transformation lead, digital or innovation professional, portfolio manager, or specialist working across quality, regulatory, operations, or technology.
You turn AI investment into credible initiatives, make informed decisions, and help those initiatives create measurable value.
You may be developing your first AI use case or improving a portfolio of existing initiatives. You do not need technical model-building experience.

Our team brings many years of experience working with AI, digital transformation, Industry 4.0, and Industry 5.0 across the pharmaceutical and life sciences value chain. We have worked with AI, digital, and automation use cases from strategy to implementation, including identifying and prioritizing use cases, building business cases, developing implementation strategies, and supporting adoption and value realization in regulated environments.
Choose quarterly or annual billing. Everything below is included in both.
Billed €477 every three months.
Billed €1,700 annually.
The focus is high-impact AI use cases and projects within pharma and life sciences organizations. These may affect processes, functions, products, decision-making, or operating models across the business.
No. We built the membership for professionals responsible for identifying, evaluating, and delivering AI initiatives. Technical specialists may support the build, while members develop the judgment and strategies needed to move the right use cases forward.
We update the use cases, technology developments, and regulatory insights as the field changes. This gives members an ongoing view of what is emerging, what is becoming practical, and what it could mean for life sciences organizations.
Some members are developing their first AI use case. Others have already delivered pilots or manage several initiatives. The shared factor is responsibility for helping AI create value in a regulated organization.
You can follow the guided material at a manageable pace and use the updates, sessions, and resources most relevant to the initiatives you currently manage.
We cover regulatory, GxP, validation, governance, and audit considerations throughout the use cases, expert sessions, and framework. This helps members identify the right questions and involve the appropriate internal experts early.
Many organizations fund professional development related to AI, digital transformation, regulatory capability, and project delivery. We designed the membership to support initiatives that can create direct organizational value.
Build a clearer view of what is changing, where AI can create meaningful value, and what it takes to move the right initiatives forward responsibly.
Apply for membership →